TerminatedNot Applicable

Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

Stopped: Loss of funding and slow enrollment

United States96 participantsStarted 2021-04-09

Plain-language summary

The purpose of this research study is to learn how cancer care providers can help their patients communicate the need for genetic testing in families with inherited cancer syndromes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕"Variant of undetermined significance," "likely benign" or "benign" variant per ACMGG criteria

What they're measuring

Proband-reported cascade testing rates of first-degree relatives

Timeframe: From start of study through completion of 6 month follow-up (estimated to be 18 months)

Number of primary barriers to genetic testing for first-degree relatives

Timeframe: From start of study through completion of 6 month follow-up (estimated to be 18 months)

Family member-reported cascade testing rates

Timeframe: From start of study through completion of 6 month follow-up (estimated to be 18 months)

Number of primary barriers to genetic testing for family members

Timeframe: From start of study through completion of 6 month follow-up (estimated to be 18 months)

Trial details

NCT IDNCT04508764

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-20

View on ClinicalTrials.gov More Hereditary Breast and Ovarian Cancer trials